The workforce reduction trend has swept the economy recently, and unfortunately, the medtech space is not immune to layoffs. You’ve probably read about the ongoing layoffs sweeping the tech industry, media and more. For instance, Yahoo, Disney, Zoom and more all reported workforce reductions as companies across industries grapple with economic pressures. Think inflation, supply […]
Verily
Verily lays off 15% of workforce
Google’s (NSDQ:GOOGL) Verily announced this week that, as part of a refined strategy, it eliminated 15% of its workforce. Verily has more than 1,600 employees, so the layoff would be more than 200 workers, according to media sites. On Jan. 11, CEO Stephen Gillett issued a letter to all Verily employees. Gillett took over the […]
ResMed partners with Verily on digital health for sleep disorders
ResMed and Google’s sister company Verily recently launched a digital health joint venture called Primasun. The companies launched the joint venture on Nov. 13 during HLTH 2022 in Las Vegas. They said Primasun will combine advanced healthcare technology and research into one comprehensive digital health platform. It will work with employers and healthcare providers to […]
7 innovative digital health offerings to treat diabetes
From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]
Verily receives $1B investment led by Alphabet, promotes president to corner office
Google’s (NSDQ:GOOGL) Verily announced today that it received a $1 billion investment led by parent company Alphabet. South San Francisco, California-based Verily plans to use the funds to expand its businesses focused on precision health. New capital will go toward a variety of its core initiatives. Those include real-world evidence generation, healthcare data, research and […]
Verily’s Onduo, Sword Health collaborate on virtual care
Onduo announced today that it entered into a strategic collaboration with Sword Health to broaden virtual care for diabetes and other conditions. Sword Health, a digital musculoskeletal (MSK) care provider, will work with Onduo by Verily, an Alphabet sister company of Google. The idea is to offer complementary solutions, broadening access to virtual care benefits for […]
FDA clears iRhythm’s ZEUS system for Zio Watch
iRhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) system. ZEUS, produced in partnership with Google’s life sciences sister company Verily, combines deep-learned algorithms with iRhythm’s cardiac arrhythmia service, providing the AI algorithm component for the Zio Watch sensor-based wearable for non-invasive, clinical-grade, long-term continuous monitoring […]
iRhythm plans silent AFib screening pilots, high-level hires and Zio Watch evaluations
iRhythm Technologies (NSDQ:IRTC) has big plans for 2022 and its remote external electrocardiogram monitors as the medical device developer gears up for growth. President and CEO Quentin Blackford is looking to hire an international general manager among other roles in the coming months, he told Medical Design & Outsourcing after presenting at this month’s 2022 J.P. Morgan Healthcare Conference, […]
FDA rejects Verily’s smartwatch-based Parkinson’s exam
The FDA issued a letter to Google’s (NSDQ:GOOGL) Verily declaring that it will not accept a letter of intent for the company’s Parkinson’s exam. Verily submitted the LOI for drug development tool (DDT) for the virtual motor exam for Parkinson’s disease. The device measures a change in digitally assessed parameters of a subset of Parkinson’s disease […]
FDA grants Verily EUA for pooled COVID-19 testing
The FDA has granted Google’s (NSDQ:GOOGL) Verily emergency use authorization (EUA) for its pooled COVID-19 testing. In a letter to the company dated yesterday, the FDA confirmed the EUA status for the qualitative test for detecting nucleic acid from SARS-CoV-2 in respiratory specimens procured through nasal, mid-turbinate, nasopharyngeal and oropharyngeal swabbing. The test also can be […]
Verily launches clinical lab for COVID-19 testing
Google’s (NSDQ:GOOGL) Verily announced that it established a CLIA-certified lab to create additional lab capacity to support COVID-19 testing. The lab, at Verily’s San Francisco headquarters, is designed to support programs in the COVID-19 testing space as demand continues to increase while the pandemic goes on, including the company’s own return-to-work efforts for its own employees, […]
